Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Cash from Financing Activities (2014 - 2023)

Mesoblast's (MEOBF) quarterly Cash from Financing Activities came in at $38.8 million in Q2 2023, up 1848.96% year-over-year from $2.0 million in Q2 2022, and up 1625.27% quarter-over-quarter from -$2.5 million in Q1 2023.

Analysis

Mesoblast (MEOBF) Cash from Financing Activities (2014 - 2023) Analysis & Trends

Mesoblast has disclosed Cash from Financing Activities across 10 years of filings, most recently posting $38.8 million for Q2 2023.

  • In Q2 2023, Cash from Financing Activities rose 1848.96% year-over-year to $38.8 million; the TTM figure through Jun 2023 stood at $74.5 million (up 854.83% YoY), while the FY2026 annual figure was -$15.3 million, down 110.4% from the prior year.
  • Cash from Financing Activities came in at $38.8 million for Q2 2023 at Mesoblast, up from -$2.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $106.4 million in Q1 2021 to a low of -$2.9 million in Q4 2021.
  • Average Cash from Financing Activities over 5 years is $17.8 million, with a median of -$390000.0 recorded in 2019.
  • Year-over-year, Cash from Financing Activities jumped 18272.22% in 2020 and slumped 294.22% in 2021.
  • Over 5 years, Cash from Financing Activities stood at $48.2 million in 2019, then sank by 101.54% to -$744000.0 in 2020, then tumbled by 294.22% to -$2.9 million in 2021, then surged by 31.4% to -$2.0 million in 2022, then jumped by 2026.29% to $38.8 million in 2023.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $38.8 million in Q2 2023, -$2.5 million in Q1 2023, and -$2.0 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 15.05 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 7.18 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 49.29 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 167.70 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 249.12 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 7.52 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn -33,000.00
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 2.69 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 38.76 Mn
Mar 31, 2023 -2.54 Mn
Dec 31, 2022 -2.01 Mn
Sep 30, 2022 40.30 Mn
Jun 30, 2022 -2.22 Mn
Mar 31, 2022 -2.57 Mn
Dec 31, 2021 -2.93 Mn
Sep 30, 2021 -2.15 Mn
Jun 30, 2021 -2.24 Mn
Mar 31, 2021 106.36 Mn
Dec 31, 2020 -744,000.00
Sep 30, 2020 6.54 Mn
Mar 31, 2020 48.13 Mn
Dec 31, 2019 48.19 Mn
Sep 30, 2019 -36,000.00
Mar 31, 2019 14.59 Mn
Dec 31, 2018 57.09 Mn
Sep 30, 2018 37.11 Mn
Jun 30, 2018 -1.01 Mn
Mar 31, 2018 31.70 Mn